<DOC>
	<DOCNO>NCT00620724</DOCNO>
	<brief_summary>The objective study determine clinical utility relate maintenance oral nifedipine therapy patient symptomatic placenta previa . This study prospective , randomize control trial inclusion , 24 week gestation , hospitalize patient symptomatic placenta praevia . All patient may initially receive oral nifedipine therapy steroid prophylaxis 48 hour . After , patient randomly assign receive either oral nifedipine ( 20 mg every 8 hour ) placebo ( one every 8 hour ) 37 week gestation . The primary outcome trial length pregnancy day enrollment . A sample size calculation design detect least 14 -day difference time gain patient maintenance oral nifedipine therapy . A sample size 52 patient per group would 80 % chance detect difference 5 % level significance .</brief_summary>
	<brief_title>Tocolytic Therapy Conservative Management Symptomatic Placenta Previa</brief_title>
	<detailed_description />
	<mesh_term>Placenta Previa</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<criteria>Placenta previa diagnose low placental edge locate within 5 cm internal o ultrasonography Placenta previa may symptomatic least one episode bleeding Estimated gestational age within 24 34 week Maternal age &gt; 18 year Informed consent receive explanation study information sheet Social affiliation Premature rupture membrane Severe bleed require immediate termination pregnancy Abnormal fetal heart rate require immediate termination pregnancy Intrauterine fetal death Preeclampsia , chorioamnionitis , liver disease , severe chronic renal disease , heart disease Abruptio placentae Nifedipine sensibility Drugs interaction nifedipine</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>